Adage Capital Partners’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$89.8K 973
2023
Q4
$89.8K Hold
20,000
﹤0.01% 798
2023
Q3
$120K Hold
20,000
﹤0.01% 805
2023
Q2
$245K Hold
20,000
﹤0.01% 796
2023
Q1
$287K Hold
20,000
﹤0.01% 828
2022
Q4
$300K Hold
20,000
﹤0.01% 872
2022
Q3
$776K Hold
20,000
﹤0.01% 899
2022
Q2
$1.53M Hold
20,000
﹤0.01% 895
2022
Q1
$971K Hold
20,000
﹤0.01% 936
2021
Q4
$1.4M Sell
20,000
-6,562
-25% -$707K ﹤0.01% 886
2021
Q3
$3.88M Sell
26,562
-10,000
-27% -$3.03M 0.01% 856
2021
Q2
$22.4M Hold
36,562
0.04% 423
2021
Q1
$25.6M Sell
36,562
-7,352
-17% -$5.29M 0.05% 370
2020
Q4
$33M Buy
+43,914
New +$30.7M 0.07% 296

Adage Capital Partners's MDVL Position: Q1 2024 in Review

Adage Capital Partners sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 20,000 shares — an estimated $89.8K sold.

Adage Capital Partners first reported a position in MDVL in Q4 2020 and held it in 13 quarters. The position peaked at $33M in Q4 2020. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

  • Adage Capital Partners reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Adage Capital Partners sold 20,000 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $89.8K.
  • Adage Capital Partners first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • Adage Capital Partners's MedAvail Holdings, Inc. Common Stock position peaked at $33M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.